Daniil Gataulin
Stock Analyst at Chardan Capital
(4.74)
# 142
Out of 4,981 analysts
110
Total ratings
59.18%
Success rate
44.87%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Initiates: Buy | $21 | $12.81 | +63.93% | 1 | Sep 15, 2025 | |
| TRML Tourmaline Bio | Downgrades: Neutral | $70 → $48 | $47.61 | +0.82% | 4 | Sep 10, 2025 | |
| QURE uniQure | Maintains: Buy | $35 | $16.49 | +112.31% | 7 | Sep 8, 2025 | |
| RGNX REGENXBIO | Maintains: Buy | $52 | $9.20 | +465.22% | 13 | Sep 8, 2025 | |
| OTLK Outlook Therapeutics | Maintains: Neutral | $3 | $1.04 | +188.46% | 10 | Aug 28, 2025 | |
| FBRX Forte Biosciences | Maintains: Buy | $61 | $10.43 | +484.85% | 6 | Aug 15, 2025 | |
| ZURA Zura Bio | Maintains: Buy | $10 | $2.00 | +400.00% | 1 | Aug 15, 2025 | |
| MGTX MeiraGTx Holdings | Maintains: Buy | $35 | $7.61 | +359.92% | 5 | Aug 15, 2025 | |
| ADVM Adverum Biotechnologies | Maintains: Buy | $33 | $3.02 | +992.72% | 8 | Aug 13, 2025 | |
| CRVO CervoMed | Maintains: Buy | $15 | $8.85 | +69.49% | 7 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 | $2.17 | +84.33% | 8 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 | $13.35 | +102.25% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 | $1.07 | +554.21% | 13 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.32 | - | 5 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $33 | $17.40 | +89.66% | 7 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $0.57 | +38,462.66% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $9.25 | - | 2 | Jul 25, 2023 |
Ocular Therapeutix
Sep 15, 2025
Initiates: Buy
Price Target: $21
Current: $12.81
Upside: +63.93%
Tourmaline Bio
Sep 10, 2025
Downgrades: Neutral
Price Target: $70 → $48
Current: $47.61
Upside: +0.82%
uniQure
Sep 8, 2025
Maintains: Buy
Price Target: $35
Current: $16.49
Upside: +112.31%
REGENXBIO
Sep 8, 2025
Maintains: Buy
Price Target: $52
Current: $9.20
Upside: +465.22%
Outlook Therapeutics
Aug 28, 2025
Maintains: Neutral
Price Target: $3
Current: $1.04
Upside: +188.46%
Forte Biosciences
Aug 15, 2025
Maintains: Buy
Price Target: $61
Current: $10.43
Upside: +484.85%
Zura Bio
Aug 15, 2025
Maintains: Buy
Price Target: $10
Current: $2.00
Upside: +400.00%
MeiraGTx Holdings
Aug 15, 2025
Maintains: Buy
Price Target: $35
Current: $7.61
Upside: +359.92%
Adverum Biotechnologies
Aug 13, 2025
Maintains: Buy
Price Target: $33
Current: $3.02
Upside: +992.72%
CervoMed
Aug 11, 2025
Maintains: Buy
Price Target: $15
Current: $8.85
Upside: +69.49%
Aug 8, 2025
Maintains: Buy
Price Target: $4
Current: $2.17
Upside: +84.33%
Aug 7, 2025
Maintains: Buy
Price Target: $27
Current: $13.35
Upside: +102.25%
Aug 4, 2025
Maintains: Buy
Price Target: $7
Current: $1.07
Upside: +554.21%
Jul 18, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.32
Upside: -
May 9, 2025
Maintains: Buy
Price Target: $28 → $33
Current: $17.40
Upside: +89.66%
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $0.57
Upside: +38,462.66%
Jul 25, 2023
Downgrades: Neutral
Price Target: n/a
Current: $9.25
Upside: -